|
1
|
Nothnick WB: The emerging use of aromatase
inhibitors for endometriosis treatment. Reprod Biol Endocrinol.
9:872011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bulun SE, Imir G, Utsunomiya H, Thung S,
Gurates B, Tamura M and Lin Z: Aromatase in endometriosis and
uterine leiomyomata. J Steroid Biochem Mol Biol. 95:57–62. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bedaiwy MA, Allaire C and Alfaraj S:
Long-term medical management of endometriosis with dienogest and
with a gonadotropin-releasing hormone agonist and add-back hormone
therapy. Fertil Steril. 107:537–548. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Surrey ES and Hornstein MD: Prolonged GnRH
agonist and add-back therapy for symptomatic endometriosis:
Long-term follow-up. Obstet Gynecol. 99:709–719. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Meng Q, Sun W, Jiang J, Fletcher NM,
Diamond MP and Saed GM: Identification of common mechanisms between
endometriosis and ovarian cancer. J Assist Reprod Genet.
28:917–923. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang S, Qiu L, Lang JH, Shen K, Huang HF,
Pan LY, Wu M, Yang JX and Guo LN: Prognostic analysis of
endometrioid epithelial ovarian cancer with or without
endometriosis: A 12-year cohort study of Chinese patients. Am J
Obstet Gynecol. 209:241 e241–e249. 2013. View Article : Google Scholar
|
|
7
|
Li F, Tie R, Chang K, Wang F, Deng S, Lu
W, Yu L and Chen M: Does risk for ovarian malignancy algorithm
excel human epididymis protein 4 and CA125 in predicting epithelial
ovarian cancer: A meta-analysis. BMC Cancer. 12:2582012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Augoulea A, Alexandrou A, Creatsa M,
Vrachnis N and Lambrinoudaki I: Pathogenesis of endometriosis: The
role of genetics, inflammation and oxidative stress. Arch Gynecol
Obst. 286:99–103. 2012. View Article : Google Scholar
|
|
9
|
Olovsson M: Immunological aspects of
endometriosis: An update. Am J Reprod Immunol. 66 Suppl
1:S101–S104. 2011. View Article : Google Scholar
|
|
10
|
Ogawa S, Kaku T, Amada S, Kobayashi H,
Hirakawa T, Ariyoshi K, Kamura T and Nakano H: Ovarian
endometriosis associated with ovarian carcinoma: A
clinicopathological and immunohistochemical study. Gynecol Oncol.
77:298–304. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Somigliana E, Vigano P, Parazzini F,
Stoppelli S, Giambattista E and Vercellini P: Association between
endometriosis and cancer: A comprehensive review and a critical
analysis of clinical and epidemiological evidence. Gynecol Oncol.
101:331–341. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vlahos NF, Kalampokas T and Fotiou S:
Endometriosis and ovarian cancer: A review. Gynecol Endocrinol.
26:213–219. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aris A: Endometriosis-associated ovarian
cancer: A ten-year cohort study of women living in the Estrie
Region of Quebec, Canada. J Ovarian Res. 3:22010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brinton LA, Lamb EJ, Moghissi KS, Scoccia
B, Althuis MD, Mabie JE and Westhoff CL: Ovarian cancer risk
associated with varying causes of infertility. Fertil Steril.
82:405–414. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siufi Neto J, Kho RM, Siufi DF, Baracat
EC, Anderson KS and Abrao MS: Cellular, histologic, and molecular
changes associated with endometriosis and ovarian cancer. J Minim
Invasive Gynecol. 21:55–63. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao C, Wu LS and Barner R: Pathogenesis
of ovarian clear cell adenofibroma, atypical proliferative
(borderline) tumor, and carcinoma: Clinicopathologic features of
tumors with endometriosis or adenofibromatous components support
two related pathways of tumor development. J Cancer. 2:94–106.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bookman MA: Optimal primary therapy of
ovarian cancer. Ann Oncol. 27 Suppl 1:i58–i62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
da Costa Miranda V, de Souza Fêde ÂB, Dos
Anjos CH, da Silva JR, Sanchez FB, da Silva Bessa LR, de Paula
Carvalho J, Filho EA, de Freitas D and Del Pilar Estevez Diz M:
Neoadjuvant chemotherapy with six cycles of carboplatin and
paclitaxel in advanced ovarian cancer patients unsuitable for
primary surgery: Safety and effectiveness. Gynecol Oncol.
132:287–291. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu X, Zheng H, Chan MT and Wu WK:
Modulation of chemoresponsiveness to platinum-based agents by
microRNAs in cancer. Am J Cancer Res. 7:1769–1778. 2017.PubMed/NCBI
|
|
20
|
Wang QE, Milum K, Han C, Huang YW, Wani G,
Thomale J and Wani AA: Differential contributory roles of
nucleotide excision and homologous recombination repair for
enhancing cisplatin sensitivity in human ovarian cancer cells. Mol
Cancer. 10:242011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Woo MG, Xue K, Liu J, McBride H and Tsang
BK: Calpain-mediated processing of p53-associated parkin-like
cytoplasmic protein (PARC) affects chemosensitivity of human
ovarian cancer cells by promoting p53 subcellular trafficking. J
Biol Chem. 287:3963–3975. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ingelmo JM, Quereda F and Acien P: Effect
of human interferon-alpha-2b on experimental endometriosis in rats:
Comparison between short and long series of treatment. Eur J Obst
Gynecol Reprod Biol. 167:190–193. 2013. View Article : Google Scholar
|
|
23
|
Sun J, Jin C, Wu H, Zhao J, Cui Y, Liu H,
Wu L, Shi Y and Zhu B: Effects of electro-acupuncture on ovarian
P450arom, P450c17α and mRNA expression induced by letrozole in PCOS
rats. PLoS One. 8:e793822013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Simsek Y, Celik O, Karaer A, Gul M, Yılmaz
E, Koc O, Colak C, Zengin S and Aydin NE: Therapeutic efficiency of
Atosiban, an oxytocin receptor blocking agent in the treatment of
experimental endometriosis. Arch Gynecol Obstet. 286:777–783. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Körbel C, Menger MD and Laschke MW: Size
and spatial orientation of uterine tissue transplants on the
peritoneum crucially determine the growth and cyst formation of
endometriosis-like lesions in mice. Hum Reprod. 25:2551–2558. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Spiers DE and Candas V: Relationship of
skin surface area to body mass in the immature rat: A
reexamination. J Appl Physiol Respir Environ Exerc Physiol.
56:240–243. 1984.PubMed/NCBI
|
|
27
|
Ceyhan ST, Onguru O, Fidan U, Ide T, Yaman
H, Kilic S and Baser I: Comparison of aromatase inhibitor
(letrozole) and immunomodulators (infliximab and etanercept) on the
regression of endometriotic implants in a rat model. Eur J Obstet
Gynecol Reprod Biol. 154:100–104. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Keenan JA, Williams-Boyce PK, Massey PJ,
Chen TT, Caudle MR and Bukovsky A: Regression of endometrial
explants in a rat model of endometriosis treated with the immune
modulators loxoribine and levamisole. Fertil Steril. 72:135–141.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Edwards AK, Nakamura DS, Virani S, Wessels
JM and Tayade C: Animal models for anti-angiogenic therapy in
endometriosis. J Reprod Immunol. 97:85–94. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Z, Liu H, He Z, Zhang G and Lang J:
Effects of cisplatin and letrozole on surgically induced
endometriosis and comparison of the two medications in a rat model.
Eur J Pharm Sci. 93:132–140. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stanic AK, Kim M, Styer AK and Rueda BR:
Dendritic cells attenuate the early establishment of
endometriosis-like lesions in a murine model. Reprod Sci.
21:1228–1236. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aydin Y, Atis A, Uludag S, Tezer I, Sakiz
D, Acar H and Toklu A: Remission of endometriosis by hyperbaric
oxygen treatment in rats. Reprod Sci. 18:941–947. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mansour G, Sharma RK, Agarwal A and
Falcone T: Endometriosis-induced alterations in mouse metaphase II
oocyte microtubules and chromosomal alignment: A possible cause of
infertility. Fertil Steril. 94:1894–1899. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen QH, Zhou WD, Pu DM, Huang QS, Li T
and Chen QX: 15-Epi-lipoxin A(4) inhibits the progression of
endometriosis in a murine model. Fertil Steril. 93:1440–1447. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sharpe-Timms KL: Using rats as a research
model for the study of endometriosis. Ann NY Acad Sci. 955:318–406.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Osteen KG, Yeaman GR and Bruner-Tran KL:
Matrix metalloproteinases and endometriosis. Semin Reprod Med.
21:155–164. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Griffioen AW and Molema G: Angiogenesis:
Potentials for pharmacologic intervention in the treatment of
cancer, cardiovascular diseases, and chronic inflammation.
Pharmacol Rev. 52:237–268. 2000.PubMed/NCBI
|
|
38
|
Ozer H, Boztosun A, Acmaz G, Atilgan R,
Akkar OB and Kosar MI: The efficacy of bevacizumab, sorafenib, and
retinoic acid on rat endometriosis model. Reprod Sci. 20:26–32.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Machado DE, Abrao MS, Berardo PT, Takiya
CM and Nasciutti LE: Vascular density and distribution of vascular
endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1)
are significantly higher in patients with deeply infiltrating
endometriosis affecting the rectum. Fertil Steril. 90:148–155.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McLaren J, Prentice A, Charnock-Jones DS
and Smith SK: Vascular endothelial growth factor (VEGF)
concentrations are elevated in peritoneal fluid of women with
endometriosis. Hum Reprod. 11:220–223. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Donnez J, Smoes P, Gillerot S,
Casanas-Roux F and Nisolle M: Vascular endothelial growth factor
(VEGF) in endometriosis. Hum Reprod. 13:1686–1690. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Dela Cruz C and Reis FM: The role of TGFβ
superfamily members in the pathophysiology of endometriosis.
Gynecol Endocrinol. 31:511–515. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang Q, Duan J, Liu X and Guo SW:
Platelets drive smooth muscle metaplasia and fibrogenesis in
endometriosis through epithelial-mesenchymal transition and
fibroblast-to-myofibroblast transdifferentiation. Mol Cell
Endocrinol. 428:1–16. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rein DT, Schmidt T, Bauerschmitz G, Hampl
M, Beyer IM, Paupoo AA, Curiel DT and Breidenbach M: Treatment of
endometriosis with a VEGF-targeted conditionally replicative
adenovirus. Fertil Steril. 93:2687–2694. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Mohamed ML, El Behery MM and Mansour SA:
Comparative study between VEGF-A and CA-125 in diagnosis and
follow-up of advanced endometriosis after conservative laparoscopic
surgery. Arch Gynecol Obstet. 287:77–82. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Perini JA, Cardoso JV, Berardo PT,
Vianna-Jorge R, Nasciutti LE, Bellodi-Privato M, Machado DE and
Abrão MS: Role of vascular endothelial growth factor polymorphisms
(−2578C>A, −460 T>C, −1154G>A, +405G>C and +936C>T)
in endometriosis: A case-control study with Brazilians. BMC Womens
Health. 14:1172014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Tamburro S, Canis M, Albuisson E,
Dechelotte P, Darcha C and Mage G: Expression of transforming
growth factor beta1 in nerve fibers is related to dysmenorrhea and
laparoscopic appearance of endometriotic implants. Fertil Steril.
80:1131–1136. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Huang HF, Hong LH, Tan Y and Sheng JZ:
Matrix metalloproteinase 2 is associated with changes in steroid
hormones in the sera and peritoneal fluid of patients with
endometriosis. Fertil Steril. 81:1235–1239. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Carmeliet P: Mechanisms of angiogenesis
and arteriogenesis. Nat Med. 6:389–395. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bulun SE: Endometriosis. N Engl J Med.
360:268–279. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Burney RO and Giudice LC: Pathogenesis and
pathophysiology of endometriosis. Fertil Steril. 98:511–519. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bulun SE, Zeitoun KM, Takayama K and
Sasano H: Molecular basis for treating endometriosis with aromatase
inhibitors. Hum Reprod Update. 6:413–418. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Abu Hashim H: Potential role of aromatase
inhibitors in the treatment of endometriosis. Int J Womens Health.
6:671–680. 2014.PubMed/NCBI
|
|
54
|
Ailawadi RK, Jobanputra S, Kataria M,
Gurates B and Bulun SE: Treatment of endometriosis and chronic
pelvic pain with letrozole and norethindrone acetate: A pilot
study. Fertil Steril. 81:290–296. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Abushahin F, Goldman KN, Barbieri E, Milad
M, Rademaker A and Bulun SE: Aromatase inhibition for refractory
endometriosis-related chronic pelvic pain. Fertil Steril.
96:939–942. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Oner G, Ozcelik B, Ozgun MT, Serin IS,
Ozturk F and Basbug M: The effects of metformin and letrozole on
endometriosis and comparison of the two treatment agents in a rat
model. Hum Rep. 25:932–937. 2010. View Article : Google Scholar
|
|
57
|
Li X, Kang X, Deng Q, Cai J and Wang Z:
Combination of a GnRH agonist with an antagonist prevents flare-up
effects and protects primordial ovarian follicles in the rat ovary
from cisplatin-induced toxicity: A controlled experimental animal
study. Reprod Biol Endocrinol. 11:162013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Blumenfeld Z, Avivi I, Linn S, Epelbaum R,
Ben-Shahar M and Haim N: Prevention of irreversible
chemotherapy-induced ovarian damage in young women with lymphoma by
a gonadotrophin-releasing hormone agonist in parallel to
chemotherapy. Hum Reprod. 11:1620–1626. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ruggiero A, Trombatore G, Triarico S,
Arena R, Ferrara P, Scalzone M, Pierri F and Riccardi R: Platinum
compounds in children with cancer: Toxicity and clinical
management. Anticancer Drugs. 24:1007–1019. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Chahvar ST, Al-Shawaf T and Tranquilli AL:
Pharmacologic ovarian preservation in young women undergoing
chemotherapy. Curr Med Chem. 21:223–229. 2014. View Article : Google Scholar : PubMed/NCBI
|
